Background Various observations have suggested that the course of COVID-19 might be
less favourable in patients with inflammatory rheumatic and musculoskeletal diseases …

Objective To report the efficacy and safety of anti-TNF agents in patients with severe and/or
refractory manifestations of Behçet's disease (BD). Methods We performed a multicenter …

Objective Hypocomplementemic urticarial vasculitis (HUV) is an uncommon vasculitis of
unknown etiology that is rarely described in the literature. We undertook this study to analyze …

Objective To analyze the factors associated with response to anti–tumor necrosis factor (anti‐TNF)
treatment and compare the efficacy and safety of infliximab (IFX) and adalimumab (…

Objective Data on adult IgA vasculitis (Henoch‐Schönlein) (IgAV) are scarce. This survey
was designed to better define the clinical spectrum of IgAV and efficacy of treatments in a …

On average, 10 % of infertile couples have unexplained infertility. Auto-immune disease (systemic
lupus erythematosus, anti-phospholipid syndrome) accounts for a part of these cases. …

Objective To describe the efficacy and safety of biologics for the treatment of eosinophilic
granulomatosis with polyangiitis (EGPA). Methods A retrospective European collaborative …

Introduction The off-label use of TNF antagonists in refractory sarcoidosis is increasingly
reported but data on their efficacy and safety are still insufficient. Objective To report on efficacy …

Background Data from the PEXIVAS trial challenged the role of plasma exchange (PLEX) in
ANCA-associated vasculitides (AAV). We aimed to describe kidney biopsy from patients with …

Objective. To report the efficacy and safety of tocilizumab (TCZ) for giant cell arteritis (GCA).
Methods. A retrospective multicenter study that included 34 patients receiving TCZ for GCA. …